Compare Cassava Sciences Inc (FLNA) vs Hims and Hers Health Inc (HIMS) Price & Performance

Cassava Sciences IncTrade

Hims and Hers Health IncTrade

Price performance (Past 24H)

Key statistics

Cassava Sciences Inc vs Hims and Hers Health Inc — how do they compare? Cassava Sciences Inc trades at $0.97 (market cap $47.75M), while Hims and Hers Health Inc trades at $30.82 (market cap $7.12B). The key difference: Hims and Hers Health Inc is far larger — about 149.1× Cassava Sciences Inc's market cap, and Hims and Hers Health Inc is trading nearer its 52-week high, Cassava Sciences Inc nearer its low. Which is the better fit depends on your goals.

	FLNA	HIMS
Market Cap	$47.75M	$7.12B
Sector	Health	Health
52-Week High	$4.64	$62.76
52-Week Low	$0.87	$14.52
Enterprise Value	-$34.93M	$7.82B

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Cassava Sciences Inc

FLNA trades at $0.9973, up 0.23% with a bearish technical signal despite recent earnings beats. The company shows negative profitability with ROE at -55.79% and ROA at -35.34%, though cash burn improved from -$33M to -$30M projected for 2026. Analyst consensus is strongly bullish with 8 buy ratings versus 4 hold ratings.

The outlook remains challenging due to persistent losses and negative cash flow, but analyst optimism and continued progress in TSC-related epilepsy therapies provide potential catalysts. Key risks include execution challenges in clinical development and the company's ability to secure additional funding.

Hims and Hers Health Inc

No Aura AI signal available yet.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

FLNA

View details →

HIMS

Hims & Hers reports strong Q2 revenue growth but wider loss amid legal challengesAndrew Wynn · 18 hours agoBearish Anthropic to embed permanent watermarks in EU AI content; Sea Limited beats Q2 revenue; 7Up refreshes flavor and branding.Seeking Alpha · 22 hours agoNeutral Hims & Hers Q2 revenue beats estimates but loss widens due to restructuring chargesProactive Investors · 1 day agoNeutral View details →

About Cassava Sciences Inc

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease

About Hims and Hers Health Inc

Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.